Geneva Partners’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,972
Closed -$1.43M 77
2024
Q3
$1.43M Buy
+3,972
New +$1.37M 0.62% 39
2021
Q4
Sell
-4,034
Closed -$1.06M 107
2021
Q3
$1.06M Buy
4,034
+1,294
+47% +$346K 0.5% 45
2021
Q2
$712K Buy
2,740
+200
+8% +$51.1K 0.33% 63
2021
Q1
$619K Sell
2,540
-1,730
-41% -$415K 0.32% 58
2020
Q4
$1.05M Buy
+4,270
New +$967K 0.55% 45
2019
Q4
Sell
-985
Closed -$213K 78
2019
Q3
$213K Hold
985
0.17% 64
2019
Q2
$202K Sell
985
-8,045
-89% -$1.54M 0.16% 63
2019
Q1
$1.78M Buy
+9,030
New +$1.63M 1.52% 27

Other funds holding SYK

Geneva Partners's SYK Position: Q4 2024 in Review

Geneva Partners sold out of Stryker (SYK) in Q4 2024, closing a stake of 3,972 shares — an estimated $1.43M sold.

Geneva Partners first reported a position in SYK in Q1 2019 and held it in 8 quarters. The position peaked at $1.78M in Q1 2019. 2,196 funds tracked by Wall St. Rank hold SYK as of Q4 2024.

  • Geneva Partners reported no remaining Stryker position as of Q4 2024 after selling out during the quarter.
  • Geneva Partners sold 3,972 Stryker shares in Q4 2024, an estimated $1.43M.
  • Geneva Partners first reported a position in Stryker in Q1 2019 and held it in 8 quarters.
  • Geneva Partners's Stryker position peaked at $1.78M in Q1 2019.
  • 2,196 funds tracked by Wall St. Rank held Stryker as of Q4 2024.

Based on Geneva Partners's 13F filing for Q4 2024, filed 27 Jan 2025.